Patients with cirrhosis who also have primary liver cancer face a higher risk for complications and death when they have portal vein thrombosis (PVT), new research confirms.
The findings highlight the need for early detection and treatment of PVT in these high-risk patients, according to study author David U. Lee, MD, an advanced hepatology fellow at Tufts Medical Center, in Boston, at the time of the study. “This study strengthens the known association between PVT and adverse outcomes in